European Case Law Identifier: | ECLI:EP:BA:2003:T083601.20031007 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 07 October 2003 | ||||||||
Case number: | T 0836/01 | ||||||||
Application number: | 97119173.9 | ||||||||
IPC class: | A61K 38/21 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | C | ||||||||
Download and more information: |
|
||||||||
Title of application: | Human interferon-Beta2A for use as a medicament | ||||||||
Applicant name: | YEDA RESEARCH AND DEVELOPMENT CO. LTD. | ||||||||
Opponent name: | - | ||||||||
Board: | 3.3.04 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: |
|
||||||||
Keywords: | Second/further medical use format (yes) Added subject-matter (no) Novelty (yes) Remittal |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t010836eu1.html
Date retrieved: 17 May 2021